CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
TIPI vaginal pessarydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01770691
NCT01770691N/ACompleted
CompareCT.gov

Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence

Assuta Hospital Systems·interventional·Posted Jan 18, 2013·Updated Jan 16, 2015

In Brief

A clinical study evaluating TIPI vaginal pessary for Stress Urinary Incontinence. Completed, enrolled 7 participants across 1 site.

Detailed Summary

Stress urinary incontinence (SUI) is most prevalent among women. SUI is characterized by loss of urine from increased abdominal pressures caused by coughing, laughing, sneezing, running, lifting or walking. SUI cause women to avoid routine physical activities, thus detracting significantly from their quality of life. The purpose of this study is to evaluate the performance of new designs of the TIPI device, a conservative, disposable, treatment for temporary management of SUI.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress Urinary Incontinence
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 18, 2013
Enrollment StartSep 1, 2007
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.5 years ago

Interventions

TIPI vaginal pessarydevice

TIPI vaginal pessary G3 model, and TIPI SMD's